Celebrating 25 Years of Scoop
Pharmac pre-empts public consultation
Dr Jackie Blue
National party Associate Health
Spokeswoman
19 December 2006
Pharmac pre-empts
public consultation
Pharmac’s preliminary conclusion that all is well with how it funds high-cost medicines is pre-empting the results of public consultation, says National’s Associate Health spokeswoman, Dr Jackie Blue.
“I don’t really hold any hope that anything will change.
“Herceptin is a classic example of why we do need to look at how high-cost drugs are funded.
“Pharmac has hidden behind its own ‘in-house’ analysis, by continuing to insist there is insufficient data to fund the breast cancer drug.
“Obviously, the 22 OECD countries that do fund Herceptin disagree. Pharmac is undoubtedly out of step.
“For Herceptin to be funded in New Zealand all 21 DHBs have to agree to fund it, and with their meagre budgets there’s no hope of that happening.
“Clearly, the way high-cost drugs are funded is being mismanaged. It’s just not working.
“There needs to be independent analysis of these drugs away from Pharmac.
“New Zealanders will miss out on lifesaving medicines if Pharmac is left to continue down the same road.
“Changes need to be made immediately.”
ENDS
Gordon Campbell: On The Royal Commission Report Into Abuse In Care
PSA: Overturning Court Of Appeal Decision On Foreshore And Seabed Is Abuse Of Power
NZ Labour Party: Charter Schools To Remove The Rights Of Teachers
Te Pāti Māori: Te iwi Māori Will Not Stand For Another Foreshore And Seabed
Cooper Legal: Lawyers For Survivors Support Royal Commission’s Call For Urgent Action
IHC New Zealand: IHC Slams Winston Peters' Use Of Retard As An Insult In Parliament
NZ Government: PM Speech To Parliament – Royal Commission Of Inquiry’s Report Into Abuse In Care
